Literature DB >> 7887441

Inhibition of growth of normal and human papillomavirus-transformed keratinocytes in monolayer and organotypic cultures by interferon-gamma and tumor necrosis factor-alpha.

P Delvenne1, W al-Saleh, C Gilles, A Thiry, J Boniver.   

Abstract

The growth response of normal and human papillomavirus (HPV)-transformed cervical keratinocytes to interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha was investigated in monolayer and organotypic raft cultures. The proliferation rates of monolayer cultures were assessed by [3H]TdR incorporation and fluorimetric DNA titration. The growth of keratinocytes in organotypic cultures was estimated by their ability to stratify on collagen rafts and by immunohistochemistry for Ki67 antigen expression. IFN-gamma reduced the DNA synthesis of normal and HPV-transformed keratinocytes in monolayer cultures and exerted a marked growth inhibitory effect in organotypic raft cultures. In control raft cultures, normal keratinocytes produced an epithelial sheet of approximately 10 cells in thickness that closely resembled normal cervical epithelium and was characterized by sparse Ki67 antigen-positive cells whereas HPV-transformed keratinocytes produced up to 15 poorly differentiated epithelial layers that were reminiscent of high grade cervical lesions seen in vivo and exhibited a full thickness Ki67 antigen expression. When normal and HPV-transformed keratinocytes were maintained in the presence of IFN-gamma, the epithelial sheet was reduced to a few cells in thickness and the density of Ki67 antigen-positive cells was decreased. A more pronounced growth inhibitory effect in monolayer and organotypic cultures was observed when IFN-gamma was associated with tumor necrosis factor-alpha Tumor necrosis factor-alpha alone reduced the DNA synthesis of normal keratinocytes but was significantly less effective than IFN-gamma to inhibit the growth of HPV-transformed keratinocytes. These results suggest that similar responses in vivo to regulatory molecules may play a role in the development of HPV-related lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7887441      PMCID: PMC1869174     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

1.  Immortalization of human cervical keratinocytes by human papillomavirus type 33.

Authors:  C Gilles; J Piette; S Rombouts; C Laurent; J M Foidart
Journal:  Int J Cancer       Date:  1993-03-12       Impact factor: 7.396

Review 2.  Keratinocytes: key immunocytes of the integument.

Authors:  B J Nickoloff; L A Turka
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

3.  Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.

Authors:  J Gerdes; R J Lelle; H Pickartz; W Heidenreich; R Schwarting; L Kurtsiefer; G Stauch; H Stein
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

4.  Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat warts.

Authors:  S Aiba; M Rokugo; H Tagami
Journal:  Cancer       Date:  1986-09-15       Impact factor: 6.860

5.  Characterization and functional analysis of the expression of intercellular adhesion molecule-1 in human papillomavirus-related disease of cervical keratinocytes.

Authors:  N Coleman; I M Greenfield; J Hare; H Kruger-Gray; B M Chain; M A Stanley
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

6.  Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines.

Authors:  C D Woodworth; S Simpson
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

7.  Immunological abnormalities in patients with cervical carcinoma.

Authors:  G Castello; G Esposito; G Stellato; L Dalla Mora; G Abate; A Germano
Journal:  Gynecol Oncol       Date:  1986-09       Impact factor: 5.482

8.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

Authors:  B J Sugarman; B B Aggarwal; P E Hass; I S Figari; M A Palladino; H M Shepard
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

9.  Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor.

Authors:  B Y Rubin; S L Anderson; S A Sullivan; B D Williamson; E A Carswell; L J Old
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

10.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.

Authors:  A D'Andrea; M Aste-Amezaga; N M Valiante; X Ma; M Kubin; G Trinchieri
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more
  10 in total

1.  Fibroblast growth factor-peptide improves barrier function and proliferation in human keratinocytes after radiation.

Authors:  Kunzhong Zhang; Yeping Tian; Liangjie Yin; Mei Zhang; Lisa A Beck; Bingrong Zhang; Paul Okunieff; Lurong Zhang; Sadasivan Vidyasagar
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-12       Impact factor: 7.038

2.  The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose.

Authors:  M Filippova; T A Brown-Bryan; C A Casiano; P J Duerksen-Hughes
Journal:  Cell Death Differ       Date:  2005-06-03       Impact factor: 15.828

3.  Anti-CD3/anti-epidermal growth factor receptor-bispecific antibody retargeting of lymphocytes against human neoplastic keratinocytes in an autologous organotypic culture model.

Authors:  Isabelle Renard; Delia Mezzanzanica; Silvana Canevari; Silvano Ferrini; Jacques Boniver; Philippe Delvenne; Nathalie Jacobs
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

4.  Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis.

Authors:  K M Detjen; K Farwig; M Welzel; B Wiedenmann; S Rosewicz
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

5.  Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models of human papillomavirus-associated (pre)neoplastic epithelial lesions.

Authors:  Pascale Hubert; Brigitte Evrard; Catherine Maillard; Elizabeth Franzen-Detrooz; Luc Delattre; Jean-Michel Foidart; Agnes Noël; Jacques Boniver; Philippe Delvenne
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

6.  Factor XIIIa-positive dendrocytes and proliferative activity of cutaneous cancers.

Authors:  C Piérard-Franchimont; J E Arrese; A F Nikkels; W al-Saleh; P Delvenne; G E Piérard
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

7.  Colonization of in vitro-formed cervical human papillomavirus- associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor.

Authors:  P Hubert; F van den Brüle; S L Giannini; E Franzen-Detrooz; J Boniver; P Delvenne
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

8.  Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression.

Authors:  Michael Herfs; Pascale Hubert; Natalia Kholod; Jean Hubert Caberg; Christine Gilles; Geert Berx; Pierre Savagner; Jacques Boniver; Philippe Delvenne
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

9.  Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix.

Authors:  W al-Saleh; P Delvenne; J E Arrese; A F Nikkels; G E Piérard; J Boniver
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Characterization of global transcription profile of normal and HPV-immortalized keratinocytes and their response to TNF treatment.

Authors:  Lara Termini; Enrique Boccardo; Gustavo H Esteves; Roberto Hirata; Waleska K Martins; Anna Estela L Colo; E Jordão Neves; Luisa Lina Villa; Luiz Fl Reis
Journal:  BMC Med Genomics       Date:  2008-06-27       Impact factor: 3.063

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.